Variant report
Variant | esv3447317 |
---|---|
Chromosome Location | chr3:195811986-195812806 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:61)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | SPI1 | chr3:195812531-195812874 | HL-60 | blood: | n/a | chr3:195812546-195812553 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:195812701-195812751 | AG09319 | gingival: | n/a |
2 | chr3:195812701-195812751 | Hela-S3 | cervix: | n/a |
3 | chr3:195812701-195812751 | ProgFib | skin: | n/a |
4 | chr3:195812701-195812751 | PrEC | prostate: | n/a |
5 | chr3:195812701-195812751 | SAEC | small airway: | n/a |
6 | chr3:195812701-195812751 | SK-N-SH_RA | brain: | n/a |
7 | chr3:195812701-195812751 | CMK | blood: | n/a |
8 | chr3:195812701-195812751 | HEK293 | kidney: | embryo |
9 | chr3:195812701-195812751 | HUVEC | blood vessel: | n/a |
10 | chr3:195812701-195812751 | HCT-116 | colon: | n/a |
11 | chr3:195812701-195812751 | LNCaP | prostate: | n/a |
12 | chr3:195812701-195812751 | ovcar-3 | ovarian: | n/a |
13 | chr3:195812701-195812751 | HMEC | breast: | n/a |
14 | chr3:195812701-195812751 | BE2_C | brain: | n/a |
15 | chr3:195812701-195812751 | GM12892 | blood: | n/a |
16 | chr3:195812701-195812751 | HRE | kidney: | n/a |
17 | chr3:195812701-195812751 | HNPCEpiC | eye: | n/a |
18 | chr3:195812701-195812751 | AG09309 | skin: | n/a |
19 | chr3:195812701-195812751 | NB4 | blood: | n/a |
20 | chr3:195812701-195812751 | SKMC | muscle: | n/a |
21 | chr3:195812701-195812751 | HCM | heart: | n/a |
22 | chr3:195812701-195812751 | RPTEC | kidney: | n/a |
23 | chr3:195812701-195812751 | HCF | heart: | n/a |
24 | chr3:195812701-195812751 | AG04449 | skin: | fetal |
25 | chr3:195812701-195812751 | HCPEpiC | choroid plexus: | n/a |
26 | chr3:195812701-195812751 | H1-hESC | embryonic stem cell: | embryo |
27 | chr3:195812701-195812751 | GM12878 | blood: | n/a |
28 | chr3:195812701-195812751 | HRPEpiC | eye: | n/a |
29 | chr3:195812701-195812751 | Hepatocyte | liver: | n/a |
30 | chr3:195812701-195812751 | BJ | skin: | n/a |
31 | chr3:195812701-195812751 | GM19239 | blood: | n/a |
32 | chr3:195812701-195812751 | K562 | blood: | n/a |
33 | chr3:195812701-195812751 | NT2-D1 | testis: | n/a |
34 | chr3:195812701-195812751 | T-47D | breast: | n/a |
35 | chr3:195812701-195812751 | HRCEpiC | kidney: | n/a |
36 | chr3:195812701-195812751 | HepG2 | liver: | n/a |
37 | chr3:195812701-195812751 | A549 | lung: | n/a |
38 | chr3:195812701-195812751 | Jurkat | blood: | n/a |
39 | chr3:195812701-195812751 | HAEpiC | amniotic membrane: | n/a |
40 | chr3:195812701-195812751 | AG04450 | lung: | fetal |
41 | chr3:195812701-195812751 | HPAEpiC | pulmonary alveolar: | n/a |
42 | chr3:195812701-195812751 | NHDF-neo | bronchial: | n/a |
43 | chr3:195812701-195812751 | HIPEpiC | eye: | n/a |
44 | chr3:195812701-195812751 | NH-A | brain: | n/a |
45 | chr3:195812701-195812751 | U87 | brain: | n/a |
46 | chr3:195812701-195812751 | SK-N-SH | brain: | n/a |
47 | chr3:195812701-195812751 | GM06990 | blood: | n/a |
48 | chr3:195812701-195812751 | MCF10A-Er-Src | breast: | n/a |
49 | chr3:195812701-195812751 | GM12891 | blood: | n/a |
50 | chr3:195812701-195812751 | AoSMC | blood vessel: | n/a |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:195793504..195812987-chr3:195901613..195938073,113 | K562 | blood: | |
2 | chr3:195807696..195810265-chr3:195811097..195814748,4 | MCF-7 | breast: | |
3 | chr3:195782593..195785081-chr3:195810748..195812447,2 | K562 | blood: | |
4 | chr3:195793504..195812415-chr3:195915832..195927942,46 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
TFRC | TF binding region |
TFRC | CpG island |
ENSG00000163958 | chromatin interactions |
ENSG00000072274 | chromatin interactions |
ENSG00000222335 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536052118 | chr3:195812018-195812019 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
2 | rs556767385 | chr3:195812033-195812034 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs182045920 | chr3:195812052-195812053 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs536107138 | chr3:195812053-195812054 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs6793116 | chr3:195812088-195812089 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs572339760 | chr3:195812118-195812119 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs6793127 | chr3:195812123-195812124 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs147682934 | chr3:195812127-195812128 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs576098345 | chr3:195812136-195812137 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs544014379 | chr3:195812159-195812160 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs6810239 | chr3:195812163-195812164 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs79088388 | chr3:195812194-195812195 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs576469050 | chr3:195812203-195812204 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs6802714 | chr3:195812220-195812221 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs527276509 | chr3:195812256-195812257 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
16 | rs552278293 | chr3:195812263-195812264 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
17 | rs148065083 | chr3:195812278-195812279 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
18 | rs537906802 | chr3:195812287-195812288 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
19 | rs550399525 | chr3:195812310-195812311 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs71621211 | chr3:195812323-195812324 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs184658196 | chr3:195812362-195812363 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
22 | rs555733826 | chr3:195812393-195812394 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
23 | rs144896798 | chr3:195812425-195812426 | Enhancers Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
24 | rs536195132 | chr3:195812429-195812430 | Enhancers Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
25 | rs141780320 | chr3:195812479-195812480 | Enhancers Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
26 | rs572429658 | chr3:195812482-195812483 | Enhancers Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
27 | rs539470156 | chr3:195812542-195812543 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
28 | rs558096249 | chr3:195812549-195812550 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
29 | rs576139400 | chr3:195812568-195812569 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
30 | rs543466834 | chr3:195812594-195812595 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
31 | rs188974606 | chr3:195812625-195812626 | Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
32 | rs574285875 | chr3:195812651-195812652 | Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
33 | rs150096056 | chr3:195812701-195812702 | Enhancers | TF binding regionCpG islandChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
34 | rs529820333 | chr3:195812737-195812738 | Enhancers | TF binding regionCpG islandChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Cancer | 16751803 | CNVD |
abnormal development | 18461090 | CNVD |
Autism | 19653912 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cervical cancer | 21062161 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 16397240 | CNVD |
Epilepsy | 20736978 | CNVD |
Mental retardation | 20736978 | CNVD |
speech impairment | 20736978 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mental retardation | 17124404 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20299530 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 21509527 | CNVD |
Cancer | 21129771 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neurodevelopmental disorder | 16760732 | CNVD |
Schizophrenia | 22118685 | CNVD |
Schizophrenia | 22958593 | CNVD |
Schizophrenia | 21285140 | CNVD |
Schizophrenia | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Autism | 20970697 | CNVD |
Developmental delay | 18471269 | CNVD |
Intellectual disability | 22045946 | CNVD |
Breast cancer | 21045282 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Uveal melanoma | 20484589 | CNVD |
3q29 microdeletion syndrome | 20500065 | CNVD |
Biliary cancer | 20453639 | CNVD |
3q29 microdeletion syndrome | 22283845 | CNVD |
3q29 microdeletion syndrome | 21626679 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:195809800-195812400 | Weak transcription | Fetal Thymus | thymus |
2 | chr3:195809800-195812600 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
3 | chr3:195810000-195812200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr3:195810000-195812400 | Weak transcription | Primary B cells from peripheral blood | blood |
5 | chr3:195810000-195812400 | Weak transcription | Primary hematopoietic stem cells | blood |
6 | chr3:195810000-195812400 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
7 | chr3:195810000-195812400 | Weak transcription | GM12878-XiMat | blood |
8 | chr3:195810000-195812400 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
9 | chr3:195810200-195812400 | Weak transcription | Primary monocytes fromperipheralblood | blood |
10 | chr3:195810200-195812400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr3:195811800-195813000 | Enhancers | K562 | blood |
12 | chr3:195812200-195813400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
13 | chr3:195812400-195812600 | Enhancers | Fetal Thymus | thymus |
14 | chr3:195812400-195812800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr3:195812400-195812800 | Enhancers | GM12878-XiMat | blood |
16 | chr3:195812400-195813000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
17 | chr3:195812400-195813200 | Enhancers | Primary monocytes fromperipheralblood | blood |
18 | chr3:195812400-195813200 | Enhancers | Primary B cells from peripheral blood | blood |
19 | chr3:195812400-195813200 | Enhancers | Primary hematopoietic stem cells | blood |
20 | chr3:195812400-195813400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
21 | chr3:195812400-195813400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
22 | chr3:195812600-195812800 | Enhancers | Primary neutrophils fromperipheralblood | blood |